An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

NCT06129240 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension
Interstitial Lung Disease

Interventions

DRUG: LIQ861

Sponsor

Liquidia Technologies, Inc.